Skip to main content

Henry Schein company profile

  • HSIC · Nasdaq
  • Distribution
  • Health Care Distributors
  • S&P 500
$86.22+0.09%Close 13 Nov 2026 · Market value $9.29B

About Henry Schein

Henry Schein distributes health care products and provides value-added services to the dental and medical markets. Its Global Distribution and Value-Added Services segment supplies national brand and corporate brand merchandise, equipment and related technical services to customers including dental practices, laboratories, physician practices, ambulatory surgery centers, government and institutional clinics, and home health providers. The company also offers practice management and other software for dental customers, homecare medical products delivered to patients, and manufactures dental implant, endodontic and orthopedic products. It markets its products in approximately 90 countries and operates distribution centers and manufacturing facilities around the world.

A summary of the business section of the company's latest annual report, filed 24 Feb 2026.

Company facts

TickerHSIC · Nasdaq
SectorDistribution
IndustryHealth Care Distributors
IndexS&P 500
Fiscal year ends27 December
Reporting currencyUSD
CIK1000228
Latest annual report10-K, filed 24 Feb 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Stanley M. BergmanFormer Director575K · 0.5%Gift, 26 May 2026
Mark E. MlotekEVP, Chief Strategic Officer67.1K · < 1%Shares withheld for tax, 16 Mar 2026
Michael S. EttingerEVP & Chief Operating Officer64.1K · < 1%Gift, 17 Mar 2026
Philip A. LaskawyDirector58.6K · < 1%Grant or award, 6 Mar 2026
Bradley T. Sheares, Ph.D.Director45.0K · < 1%Grant or award, 6 Mar 2026
Ronald N. SouthSVP & Chief Financial Officer38.6K · < 1%Shares withheld for tax, 16 Mar 2026
Anne H. MarguliesDirector27.8K · < 1%Grant or award, 6 Mar 2026
Joseph L. HerringDirector27.7K · < 1%Grant or award, 6 Mar 2026
Andrea AlbertiniCEO, Global Dist. & Tech.26.6K · < 1%Shares withheld for tax, 8 Sep 2026
Mohamad AliDirector13.7K · < 1%Grant or award, 6 Mar 2026
Deborah DerbyDirector13.3K · < 1%Grant or award, 6 Mar 2026
Kurt P. KuehnDirector12.8K · < 1%Open-market sale, 10 Mar 2026
William K. “Dan” DanielDirector10.0K · < 1%Grant or award, 12 Jun 2026
Scott SerotaDirector9.2K · < 1%Grant or award, 6 Mar 2026
Carole T. FaigDirector5.4K · < 1%Grant or award, 6 Mar 2026
Robert J. HombachDirector2.8K · < 1%Grant or award, 6 Mar 2026
Frederick M. LoweryCEO · Director0 · < 1%Grant or award, 6 Mar 2026
Popeck Thomas CCEO, Henry Schein Products—Open-market sale, 19 Mar 2026
Sheehy Christine ZayacSVP, Chief Human Res. Officer—Shares withheld for tax, 16 Mar 2026
Tuckson Reed VaughnDirector—Grant or award, 6 Mar 2026

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

HSIC in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.